Five-year data support ctDNA liquid biopsies to guide colon cancer treatment
Updated results of an Australian trial which used liquid biopsies to guide colon cancer treatment has confirmed no compromise ...
Minimally invasive prostate cancer treatment shows success in first patient
Bill Faulkner had long approached prostate cancer testing with skepticism. For almost a decade, the 73-year-old had avoided ...
TMCnet4d
Fusion Biopsy Market is expected to generate a revenue of USD 1448.15 Million by 2032, Globally, at 8.9% CAGR: Verified Market Research®
The Global Fusion Biopsy Market Size is projected to grow at a CAGR of 8.9% from 2025 to 2032, according to a new report published by Verified Market Research ®. The report reveals that the market was ...
Physician's Weekly5d
Ultra-Rapid Molecular-Genetic Assays Feasible for Tumor Classification During Surgery
Intraoperative ultra-rapid droplet digital polymerase chain reaction (UR-ddPCR) can identify tumor genetic subtype and ...
Biopsy Devices Market worth US$11.01 billion by 2030 with 7.2% CAGR | MarketsandMarkets™
The global Biopsy Devices Market, valued at US$6.86 billion in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching ...
Business Wire6d
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
Personalis, Inc. (Nasdaq: PSNL), in collaboration with Professor Nick Turner, Dr. Isaac Garcia-Murillas and their colleagues at The Institute of Cance ...